 |
PDBsum entry 4z2b
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4z2b
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.13.4
- poly(A)-specific ribonuclease.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Exonucleolytic cleavage of poly(A) to 5'-AMP.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
290:19681-19696
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.
|
|
E.R.Wood,
R.Bledsoe,
J.Chai,
P.Daka,
H.Deng,
Y.Ding,
S.Harris-Gurley,
L.H.Kryn,
E.Nartey,
J.Nichols,
R.T.Nolte,
N.Prabhu,
C.Rise,
T.Sheahan,
J.B.Shotwell,
D.Smith,
V.Tai,
J.D.Taylor,
G.Tomberlin,
L.Wang,
B.Wisely,
S.You,
B.Xia,
H.Dickson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
2',5'-Oligoadenylate synthetase (OAS) enzymes and RNase-L constitute a major
effector arm of interferon (IFN)-mediated antiviral defense. OAS produces a
unique oligonucleotide second messenger, 2',5'-oligoadenylate (2-5A), that binds
and activates RNase-L. This pathway is down-regulated by virus- and host-encoded
enzymes that degrade 2-5A. Phosphodiesterase 12 (PDE12) was the first cellular
2-5A- degrading enzyme to be purified and described at a molecular level.
Inhibition of PDE12 may up-regulate the OAS/RNase-L pathway in response to viral
infection resulting in increased resistance to a variety of viral pathogens. We
generated a PDE12-null cell line, HeLaΔPDE12, using transcription
activator-like effector nuclease-mediated gene inactivation. This cell line has
increased 2-5A levels in response to IFN and poly(I-C), a double-stranded RNA
mimic compared with the parental cell line. Moreover, HeLaΔPDE12 cells were
resistant to viral pathogens, including encephalomyocarditis virus, human
rhinovirus, and respiratory syncytial virus. Based on these results, we used
DNA-encoded chemical library screening to identify starting points for inhibitor
lead optimization. Compounds derived from this effort raise 2-5A levels and
exhibit antiviral activity comparable with the effects observed with PDE12 gene
inactivation. The crystal structure of PDE12 complexed with an inhibitor was
solved providing insights into the structure-activity relationships of inhibitor
potency and selectivity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |